See if 12-lead ECG can predict S-ICD eligibility for adults
Official title: Identifying Electrocardiographic Markers on a Standard 12-lead ECG to Determine Which Patients Are Eligible for the Implantation of a Subcutaneous Defibrillator.
Run by Nantes University Hospital · NCT07157449 · Data updated 2026-11-12
This study tests whether a standard 12-lead ECG can predict who is suitable for a subcutaneous defibrillator (S-ICD) before implantation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 1 site (Nantes, Nantes) |
| Status | Recruiting |
| Started | January 27, 2026 |
| Main results expected | October 31, 2026 |
| Study ends | June 1, 2027 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT07157449 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 undergoing cardiology consultation who consent to participate and are affiliated with social security.
✕Probably not a fit
Patients whose ECGs are not predictive of S-ICD eligibility or who do not ultimately receive an S-ICD won't benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects routine care data to determine if a 12-lead ECG can forecast S-ICD screening outcomes. Eligible patients are adults undergoing cardiology consultation who consent to participate, with data recorded in a secure electronic form. Researchers will use deep learning on the ECG data to predict S-ICD eligibility without requiring additional invasive tests. There is no follow-up beyond data collection, and outcomes will be analyzed to assess predictive accuracy. The study is conducted at Nantes University Hospital and CHU de Nantes.
Why it matters
Potential benefit: If successful, the approach could reduce unnecessary S-ICD screening and guide planning for patients who may benefit from the device.
How similar studies have gone: Previous work has explored ECG-based prediction methods, but using a standard 12-lead ECG to predict S-ICD eligibility is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria : * Patient undergoing cardiology consultation, whatever the pathology * Patient over 18 years of age * Patient having been informed and having given their oral non-opposition * Patient and relatives affiliated to a social security scheme Exclusion Criteria : * Patients receiving cardiac stimulation * Patient taking part in a therapeutic trial which may interfere with the results of the research * Patients under guardianship.
Where it's running
-
CHU de Nantes
Nantes, Nantes, France Recruiting
Study contacts
- Principal investigator: Vincent Probst — Nantes University Hospital
- Study coordinator: Vincent Probst, PU-PH
- Email: vincent.probst@chu-nantes.fr
- Phone: 02 40 16 56 99
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heart rate and respiration monitoring device: performance and usability in patients of all ages
We’re testing a new physiological monitor to see how well it works and how easy it is to use for patients from newborns to seniors.
-
Four-session focal shock wave therapy for vulvodynia in women
This study looks at whether four weekly sessions of low-intensity focal shock wave therapy help women with vulvodynia in real-life clinical practice.
-
Reproducibility of Digital Bite Mark Overlays in Adults
This study tests how consistently different people can create digital bite mark overlays from 3D dental scans in adults who need routine dental care.
-
Dental care for people living with HIV in Pays de la Loire
This study looks at whether people living with HIV in Pays de la Loire need any special dental management based on their health data.
-
68Ga-FAPI-46 PET imaging to stage ATTR-CM and spot progression
This study tests whether a gallium-68 labeled FAPI PET scan can help stage transthyretin cardiac amyloidosis and identify patients whose disease is progressing.
-
IL-1β blocker after pancreatic transplant to help prevent graft thrombosis
This trial tests whether adding Anakinra right after pancreatic transplant is safe for patients to see if it helps protect the new pancreas.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.